Revision history of "Telemedicine in Radiation Oncology PostCOVID19 Outbreak Theres no Going back"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 12:16, 13 May 2024Gongfield94 (Talk | contribs). . (3,461 bytes) (+3,461). . (Created page with "Finally, we all assessed two CD169-targeting nanovaccine platforms, antibody-based and liposome-based, and we indicated that CD169+ monocytes proficiently introduced tumor-ass...")